At the current time, it's not recommended that BRCA2 testing be performed for the general population. Instead, those who have ...

Alternatively, the same BRCA deficiency that prompted genomic ... and these three studies provide a compelling rationale for testing combinations of cisplatin with agents that target pathways ...

Thank you for taking time to provide your feedback to the editors. Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.

better known as BRCA2. This discovery transformed the field of cancer research, leading to genetic testing in breast, ovarian and prostate cancer and then PARP inhibitors for all three, and has had an ...

BRCA mutations are inextricably linked with breasts, but they can also lead to cancer in the pancreas, the prostate, and ...

Credit: Luke Henry, ICR. Many more people with breast cancer could get tested for mutations in the BRCA1 and BRCA2 genes under new criteria, a study suggests. Researchers are recommending new criteria ...

Brenda and Mary chose to undergo BRCA1/BRCA2 testing, and they both tested positive for a BRCA1 mutation. The other 2 sisters, Linda and Arlene, chose to undergo intensive surveillance rather than ...

The BRCA-DIRECT study, carried out by The Institute of Cancer Research (ICR), tested two different ways of sharing ...

Jewish people in England are being invited to take part in a gene testing programme to identify carriers of BRCA mutations that elevate their risk of breast cancer. The NHS Jewish BRCA Testing ...

My mom's positive test for the BRCA2 gene mutation was as crushing as it was relieving. It was crushing because it provided evidence that the mutation ran in the family and that I had an increased ...

women are at low risk for developing BRCA-mutation-associated breast or ovarian cancer. Furthermore, they found fair evidence of ethical, legal, and social harms associated with testing and cited ...